OpenVSafe by OpenVAERS
Search V-safe

F9Y-18806-42091

2 vaccinations 5 coded responses 11 check-ins 5 free-text entries 3 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
207 / MD
Registered
2021-01-02
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-15
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-02
    Registered in v-safe
  3. 2021-01-02
    Survey response — day 14, dose 1
    MedDRA: Eye discharge, Eye infection, Impetigo, Nasal crusting, Nasal discomfort — Feeling: Good
    Free text: 1. Right eye injection and discharge x 12 hours2. Left focal nasal mucosal irritation/scab formation. Appears impetgo- like.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-06
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-01-07
    Health check-in — day 28, dose 1
    Feeling: Fair
    Adult check-in
  6. 2021-01-12
    Dose 2 — Pfizer-BioNTech
  7. 2021-01-26
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  8. 2021-02-04
    Survey response — day 21, dose 2
    MedDRA: Lymphadenopathy, Rash, Rash papular — Feeling: Good
    Free text: 1. ~3cm enlarged anterior cervical lymph node, appeared 5-6 days after 2nd shot (1/12) and is still present. 2. 3 erythematous papules about 3-4mm in diameter, now present for ~7 days in hand and distal Arm. One on ventral hand surface.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-02-09
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-02-16
    Survey response — day 35, dose 2
    MedDRA: Vasculitic rash — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Vascular rash (awaiting biopsy results)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-16
    Report sent to call center — day 35, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  12. 2021-02-23
    Survey response — day 42, dose 2
    MedDRA: Vasculitic rash — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: My vasculitic rash is worsening. Have a biopsy pending.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-02-23
    Report sent to call center — day 42, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  14. 2021-04-13
    Survey response — 3 months, dose 2
    MedDRA: Idiopathic intracranial hypertension, Rheumatic disorder, Sarcoidosis — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: 1. Idiopathic intracranial hypertension2. Suspected new-onset rheum dz thought to be sarcoidosis
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-13
    Report sent to call center — 3 months, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  16. 2021-06-15
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  17. 2021-07-15
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2022-01-12
    Health check-in — 12 months, dose 2
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-15Pfizer-BioNTech
22021-01-12Pfizer-BioNTech

Call center

3 call center cases

3 successful

VAERS report filed, before or during a call: 3

See the call center timeline

Free text

Release 1 — day 14, dose 1

2021-01-02

Symptoms: 1. Right eye injection and discharge x 12 hours2. Left focal nasal mucosal irritation/scab formation. Appears impetgo- like.

Release 3 — day 21, dose 2

2021-02-04

Symptoms: 1. ~3cm enlarged anterior cervical lymph node, appeared 5-6 days after 2nd shot (1/12) and is still present. 2. 3 erythematous papules about 3-4mm in diameter, now present for ~7 days in hand and distal Arm. One on ventral hand surface.

Release 4 — day 35, dose 2

2021-02-16

Symptoms: Vascular rash (awaiting biopsy results)

Release 4 — day 42, dose 2

2021-02-23

Symptoms: My vasculitic rash is worsening. Have a biopsy pending.

Release 7 — 3 months, dose 2

2021-04-13

Symptoms: 1. Idiopathic intracranial hypertension2. Suspected new-onset rheum dz thought to be sarcoidosis

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDEye discharge ✓ ✓ ✓
SDEye infection ✓ ✓ ✓
SDIdiopathic intracranial hypertension ✓ ✓ ✓
SDImpetigo ✓ ✓ ✓
SDLymphadenopathy ✓ ✓ ✓
SDNasal crusting ✓ ✓ ✓
SDNasal discomfort ✓ ✓ ✓
SDRash ✓ ✓ ✓
SDRash papular ✓ ✓ ✓
SDRheumatic disorder ✓ ✓ ✓
SDSarcoidosis ✓ ✓ ✓
SDVasculitic rash ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release